These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Absence of avidity maturation of autoantibodies to the protein tyrosine phosphatase-like IA-2 molecule and glutamic acid decarboxylase (GAD65) during progression to type 1 diabetes. Westerlund A; Ankelo M; Ilonen J; Knip M; Simell O; Hinkkanen AE J Autoimmun; 2005 Mar; 24(2):153-67. PubMed ID: 15829408 [TBL] [Abstract][Full Text] [Related]
25. A patient with post-traumatic stress disorder developing stiff person syndrome: is there a correlation? Dinnerstein E; Collins D; Berman SA Cogn Behav Neurol; 2007 Jun; 20(2):136-7. PubMed ID: 17558259 [TBL] [Abstract][Full Text] [Related]
26. Autoimmunity to glutamic acid decarboxylase in the neurodegenerative disorder Batten disease. Ramirez-Montealegre D; Chattopadhyay S; Curran TM; Wasserfall C; Pritchard L; Schatz D; Petitto J; Hopkins D; She JX; Rothberg PG; Atkinson M; Pearce DA Neurology; 2005 Feb; 64(4):743-5. PubMed ID: 15728308 [TBL] [Abstract][Full Text] [Related]
27. Antibodies as predictors of insulin-dependent diabetes mellitus before the clinical onset. Tuomilehto J; Ylihärsilä H Nutrition; 1998 Apr; 14(4):403-5. PubMed ID: 9591316 [No Abstract] [Full Text] [Related]
29. Stiff person syndrome with cerebellar disease and high-titer anti-GAD antibodies. Rakocevic G; Raju R; Semino-Mora C; Dalakas MC Neurology; 2006 Sep; 67(6):1068-70. PubMed ID: 17000981 [TBL] [Abstract][Full Text] [Related]
30. [Cytoplasmic islet cell antibodies and GAD antibodies in diagnosis of diabetes]. Bieg S; Seissler J; Scherbaum WA Med Klin (Munich); 1995 Oct; 90(10):594-8. PubMed ID: 7500923 [No Abstract] [Full Text] [Related]
31. Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Baekkeskov S; Aanstoot HJ; Christgau S; Reetz A; Solimena M; Cascalho M; Folli F; Richter-Olesen H; De Camilli P Nature; 1990 Sep; 347(6289):151-6. PubMed ID: 1697648 [TBL] [Abstract][Full Text] [Related]
32. [Stiff-man syndrome from the perspective of internal medicine and immunology]. Seissler J; Scherbaum WA Internist (Berl); 2000 May; 41(5):460-6. PubMed ID: 10867902 [No Abstract] [Full Text] [Related]
33. Response to steroid treatment in anti-glutamic acid decarboxylase antibody-associated cerebellar ataxia, stiff person syndrome and polyendocrinopathy. Kim JY; Chung EJ; Kim JH; Jung KY; Lee WY Mov Disord; 2006 Dec; 21(12):2263-4. PubMed ID: 17013903 [No Abstract] [Full Text] [Related]
34. [Stiff person syndrome--case report]. Tomczykiewicz K; Pastuszak Z; Staszewski J; Stepień A Pol Merkur Lekarski; 2014 Jan; 36(211):28-30. PubMed ID: 24645574 [TBL] [Abstract][Full Text] [Related]
35. Stiff leg syndrome: case report. Gürol ME; Ertas M; Hanagasi HA; Sahin HA; Gürsoy G; Emre M Mov Disord; 2001 Nov; 16(6):1189-93. PubMed ID: 11748762 [TBL] [Abstract][Full Text] [Related]
36. Glutamic acid decarboxylase antibodies in idiopathic generalized epilepsy and type 1 diabetes. Striano P; Perruolo G; Errichiello L; Formisano P; Beguinot F; Zara F; Striano S Ann Neurol; 2008 Jan; 63(1):127-8. PubMed ID: 17167787 [No Abstract] [Full Text] [Related]
38. GAD, diabetes, and Stiff-Man syndrome: some progress and more questions. Solimena M; Butler MH; De Camilli P J Endocrinol Invest; 1994; 17(7):509-20. PubMed ID: 7829825 [No Abstract] [Full Text] [Related]
39. [Antibodies to glutamic acid decarboxylase (GADA) as markers of risk for development of insulin-dependent diabetes mellitus]. Kretowski A; Szelachowska M; Kowalska I; Peczyńska J; Urban M; Kinalska I Przegl Lek; 1998; 55(6):315-9. PubMed ID: 9857706 [TBL] [Abstract][Full Text] [Related]
40. The $64000 question in diabetes continues. Atkinson MA Lancet; 2000 Jul; 356(9223):4-6. PubMed ID: 10892753 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]